Categories AlphaGraphs, Earnings, Technology
Oracle crushes Q4 earnings, revenue expectations; stock spikes
Software giant Oracle (NYSE: ORCL) reported stronger than expected earnings and revenues for the fourth quarter, driving the stock sharply higher during Wednesday’s after-hours trading session.
At $1.16 per share, adjusted net income was up 23% from the comparable period of 2018 and above Wall Street’s projection. Reported profit rose to $3.74 billion or $1.07 per share in the May quarter from $3.28 billion or $0.79 per share a year earlier.
Though the ongoing slump in the core segments weighed down on sales, revenues moved up 1% to $11.1 billion in the fourth quarter and surpassed the consensus estimate. Cloud Services and License Support revenues were flat year-over-year at $6.8 billion, while Cloud License and On-Premise License revenues rose 12% to $2.5 billion. The top-line benefited from the strong performance by the Fusion and NetSuite cloud applications.
Cloud Services and License Support revenues were flat, while Cloud License and On-Premise License revenues rose 12%
“Our high-margin Fusion and NetSuite cloud applications businesses are growing rapidly, while we downsize our low-margin legacy hardware business. The net result of this shift away from commodity hardware to cloud applications was a Q4 non-GAAP operating margin of 47%, the highest we’ve seen in five years,” said CEO Safra Catz.
Oracle’s sales remain under pressure even as the company continues its transition from conventional computing to the cloud space. The shift in business model keeps posing challenges, in terms of revenue performance.
The company’s board of directors declared a quarterly cash dividend of $0.24 per share, which will be paid on July 31, 2019, to stockholders of record on July 17, 2019.
Shares of Oracle hovered near the peak once again this week, after retreating from last month’s record high. The stock’s movement in the coming days might be influenced by the management’s outlook for fiscal 2019. It closed Wednesday’s regular session lower but gained sharply in the after-hours following the earnings report.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Comments